Seguir
Jacob H. Levine
Jacob H. Levine
Dirección de correo verificada de columbia.edu
Título
Citado por
Citado por
Año
viSNE enables visualization of high dimensional single-cell data and reveals phenotypic heterogeneity of leukemia
ED Amir, KL Davis, MD Tadmor, EF Simonds, JH Levine, SC Bendall, ...
Nature biotechnology 31 (6), 545-552, 2013
13792013
Data-driven phenotypic dissection of AML reveals progenitor-like cells that correlate with prognosis
JH Levine, EF Simonds, SC Bendall, KL Davis, DA El-ad, MD Tadmor, ...
Cell 162 (1), 184-197, 2015
13702015
Distinct cellular mechanisms underlie anti-CTLA-4 and anti-PD-1 checkpoint blockade
SC Wei, JH Levine, AP Cogdill, Y Zhao, NAAS Anang, MC Andrews, ...
Cell 170 (6), 1120-1133. e17, 2017
8672017
Innate immune landscape in early lung adenocarcinoma by paired single-cell analyses
Y Lavin, S Kobayashi, A Leader, ED Amir, N Elefant, C Bigenwald, ...
Cell 169 (4), 750-765. e17, 2017
8012017
An immune atlas of clear cell renal cell carcinoma
S Chevrier, JH Levine, VRT Zanotelli, K Silina, D Schulz, M Bacac, ...
Cell 169 (4), 736-749. e18, 2017
6442017
Persistent sonic hedgehog signaling in adult brain determines neural stem cell positional identity
RA Ihrie, JK Shah, CC Harwell, JH Levine, CD Guinto, M Lezameta, ...
Neuron 71 (2), 250-262, 2011
2582011
Environmental control of kisspeptin: implications for seasonal reproduction
TJ Greives, AO Mason, MAL Scotti, J Levine, ED Ketterson, LJ Kriegsfeld, ...
Endocrinology 148 (3), 1158-1166, 2007
2442007
Characterization of cell fate probabilities in single-cell data with Palantir
M Setty, V Kiseliovas, J Levine, A Gayoso, L Mazutis, D Pe’Er
Nature biotechnology 37 (4), 451-460, 2019
1932019
Combination anti–CTLA-4 plus anti–PD-1 checkpoint blockade utilizes cellular mechanisms partially distinct from monotherapies
SC Wei, NAAS Anang, R Sharma, MC Andrews, A Reuben, JH Levine, ...
Proceedings of the National Academy of Sciences 116 (45), 22699-22709, 2019
1752019
Suppression of kisspeptin expression and gonadotropic axis sensitivity following exposure to inhibitory day lengths in female Siberian hamsters
AO Mason, TJ Greives, MAL Scotti, J Levine, S Frommeyer, ED Ketterson, ...
Hormones and behavior 52 (4), 492-498, 2007
1042007
Amir el
JH Levine, EF Simonds, SC Bendall, KL Davis
AD, Tadmor, MD, Litvin, O., Fienberg, HG, Jager, A., Zunder, ER, et al, 184-197, 2015
602015
Negative co-stimulation constrains T cell differentiation by imposing boundaries on possible cell states
SC Wei, R Sharma, NAAS Anang, JH Levine, Y Zhao, JJ Mancuso, ...
Immunity 50 (4), 1084-1098. e10, 2019
572019
Geographic atrophy in age-related macular degeneration and TLR3
AS Lewin
N Engl J Med 360 (21), 2251, 2009
422009
AD Amir el, MD Tadmor, O
JH Levine, EF Simonds, SC Bendall, KL Davis
Litvin, HG Fienberg, A. Jager, ER Zunder, R. Finck, AL Gedman, I. Radtke, JR …, 2015
272015
Palantir characterizes cell fate continuities in human hematopoiesis
M Setty, V Kiseliovas, J Levine, A Gayoso, L Mazutis, D Pe’er
BioRxiv, 385328, 2018
132018
Negative costimulation constrains T cell differentiation
SC Wei, R Sharma, NA Anang, J Levine, Y Zhao, J Wang, D Pe’er, ...
The Journal of Immunology 200 (1 Supplement), 171.17-171.17, 2018
2018
Distinct cellular mechanisms mediate anti-CTLA-4 and anti-PD-1 checkpoint blockade
SC Wei, JH Levine, D Pe'er, JP Allison
Cancer Research 77 (13_Supplement), 592-592, 2017
2017
Learning cell states from high-dimensional single-cell data
JH Levine
Columbia University, 2016
2016
Abstract A32: Computational dissection of phenotypic and functional heterogeneity in acute myeloid leukemia.
JH Levine, EF Simonds, SC Bendall, GP Nolan, D Pe'er
Clinical Cancer Research 21 (17_Supplement), A32-A32, 2015
2015
Abstract IA30: Towards rationale therapy: Dealing with intertumor and intratumor heterogeneity
ED Amir, O Litvin, J Levine, SC Bendall, KL Davis, EF Simonds, T Schild, ...
Cancer Research 73 (19_Supplement), IA30-IA30, 2013
2013
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20